It’s a challenge, being a challenger brand today. The relative ease and speed with which you can bring a company or product to market means the volume of brands in any given space is huge, so conveying genuine differentiation is hard. And staying the course, building a challenger that lasts, is even harder.
Running a small business can be hugely rewarding but also hugely frustrating. You have the perfect product, website and sales process in front of you, but getting in front of the perfect customer, and then scaling this, is a battle that we have all have to face. Often, SMEs will be time poor and resource limited, with individuals covering a range of different roles, making it hard to scale effectively.
The future of the office remains uncertain, and the recent speculation around changes to the right to work away from the office only muddies the waters further. Regardless, many large businesses such as Amazon are already planning their return to an office-centric culture to enable collaboration. Google also revealed that 60% of its workforce would be in the office a few days a week, with only 20% of the workforce working remotely.
Every three seconds someone develops Alzheimer’s. And although there are currently 44 million people worldwide living with the disease, there has been no new treatment approved in the last 14 years and over 400 clinical studies have failed. There has been €540bn spent on Alzheimer’s and Dementia globally. It has also been estimated that the number of Alzheimer’s patients are expected to triple by 2050.
Fertility, menopause, maternity and gender confirmation benefits are often only available from health and wellbeing packages for the very largest corporations. As a specialist in supporting SMEs and startups, Towergate Health & Protection is now making this level of progressive care accessible to companies of all sizes.
Desana, a startup transforming how global employers utilise workspace, has announced that it has raised a $4m seed round. The oversubscribed round was led by Berlin-based PropTech 1 Ventures, BGF and existing investor Techstart Ventures, with participation from GroundBreak Ventures and the Accel Scout programme.
Israeli startup, AiVF has unveiled a scientific study which shows for the first time that genetic characteristics in embryos can be extracted using novel AI-based computer vision technologies. The study, presented this week at the prestigious ESHRE (European Society of Human Reproduction and Embryology) annual conference, was carried out by researchers at AiVF, which specialises in AI technology for digitising IVF (In Vitro Fertilisation) clinics, together with researchers led by Dr. Marcos Meseguer from the IVIRMA clinic in Valencia, Spain.












